Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1105)

Company Market Cap Price
MDCX Medicus Pharma Ltd. Common Stock
D-MNA is a medical device delivering therapy; fits Medical Devices & Biometrics.
$44.82M
$2.03
+2.53%
TELA TELA Bio, Inc.
TELA Bio manufactures OviTex Reinforced Tissue Matrix, a medical device/biomaterial used in soft tissue reconstruction, aligning with Medical Devices & Biometrics.
$44.37M
$1.13
-0.88%
RFL Rafael Holdings, Inc.
VECTR System and other devices place the company under Medical Devices & Biometrics as a broader category.
$42.81M
$1.25
+2.89%
MDAI Spectral AI, Inc.
DeepView is a diagnostic imaging device used to detect and manage wounds, fitting Diagnostic Equipment.
$42.50M
$1.59
+2.24%
ZJYL Jin Medical International Ltd.
The company designs, manufactures, and sells rehabilitation medical devices and biometrics-oriented equipment.
$40.91M
$0.26
-1.16%
PRPO Precipio, Inc.
Laboratory testing and advisory services as outsourced testing and regulatory support.
$38.47M
$24.28
+8.98%
ICCM IceCure Medical Ltd
IceCure manufactures liquid nitrogen-based cryoablation medical devices (ProSense/XSEN) used for tumor destruction, i.e., medical devices & biometrics.
$38.39M
$0.70
+0.14%
ECOR electroCore, Inc.
Directly markets and sells neuromodulation medical devices (gammaCore, Quell, Truvaga, Sparrow Ascent, TAC-STIM).
$37.16M
$4.97
+0.91%
BDMD Baird Medical Investment Holdings Limited
BDMD is a medical device manufacturer focused on microwave ablation systems and related hardware, a core medical devices category.
$36.21M
$1.44
+1.41%
POCI Precision Optics Corporation, Inc.
The business includes design and manufacture of components/subassemblies for medical devices, i.e., Medical Device Components.
$35.80M
$4.57
+1.78%
NMTC NeuroOne Medical Technologies Corporation
Core product category: neuromodulation devices used to treat epilepsy and pain via brain stimulation and ablation.
$34.86M
$0.71
+3.77%
VNRX VolitionRx Limited
VolitionRx's Nu.Q platform enables liquid biopsy cancer diagnostics by detecting nucleosome/epigenetic biomarkers in blood.
$33.49M
$0.31
+3.98%
HBIO Harvard Bioscience, Inc.
HBIO generates recurring revenue from consumables used with its medical devices and bioproduction platforms (biochips, reagents, etc.).
$33.37M
$0.75
+1.78%
RMTI Rockwell Medical, Inc.
Rockwell Medical's core offerings are dialysis-related consumables (acid and bicarbonate concentrates, single-use bicarbonate cartridge, and at-home packs) used with dialysis equipment.
$33.02M
$0.96
+4.81%
MYO Myomo, Inc.
MyoPro is a prosthetic upper-limb device designed to replace or assist movement for partially paralyzed limbs, fitting Prosthetics & Implants.
$32.64M
$0.87
+3.99%
RDGL Vivos Inc.
The company designs, develops, and sells medical devices (RadioGel/IsoPet) used in oncology.
$32.55M
$0.07
FEMY Femasys Inc.
Femasys manufactures medical devices and biometrics for women's reproductive health (FemBloc, FemaSeed, FemVue, etc.).
$32.27M
$1.00
+0.44%
YI 111, Inc.
Private label medical devices and biometrics offerings under the healthcare product lineup.
$31.21M
$3.65
+4.29%
NOTV Inotiv, Inc.
Provides outsourced laboratory testing and advisory services in nonclinical toxicology and related analyses.
$29.91M
$0.86
+3.31%
KTCC Key Tronic Corporation
Vietnam medical device manufacturing capability highlighted, aligning with Medical Devices & Biometrics.
$29.30M
$2.70
+3.05%
ELUT Elutia Inc.
Elutia's EluPro is a cardiology device used with cardiac implanted electronic devices (CIEDs), directly tying to Cardiology Devices.
$28.53M
$0.68
+9.26%
LESL Leslie's, Inc.
AccuBlue water-testing systems and related diagnostic testing capabilities are direct testing instruments offered to customers.
$27.54M
$3.03
+1.00%
DRIO DarioHealth Corp.
Integrated Medical Devices & Biometrics (smart glucose meters and biofeedback sensors) are part of the offering.
$27.23M
$12.09
+1.34%
TLPH Talphera, Inc.
Ready-to-use syringe formats place Talphera in the medical devices/biometrics category related to injectable drug delivery.
$26.88M
$1.31
-0.38%
NRXS NeurAxis, Inc.
Core product line: Neuromodulation devices (IB-Stim PENFS).
$26.32M
$2.71
+2.08%
CLGN CollPlant Biotechnologies Ltd.
CollPlant's regenerative implants and dermal fillers are medical devices, aligning with Medical Devices & Biometrics.
$25.54M
$2.13
-4.69%
RVP Retractable Technologies, Inc.
Core product category directly manufactured and sold: passive-safety syringes designed to prevent needlestick injuries.
$24.61M
$0.85
+2.91%
WETH Wetouch Technology Inc.
Medical applications revenue suggests involvement as a component provider in medical devices, i.e., Medical Device Components.
$24.58M
$2.08
+3.48%
DARE Daré Bioscience, Inc.
Medical Devices & Biometrics: Ovaprene, DARE-HRT1, DARE-LARC1 (IDDS-based), DARE-HPV vaginal insert, and related intravaginal delivery devices are device-based products.
$24.40M
$1.85
+4.52%
MLSS Milestone Scientific Inc.
Direct dental equipment manufacturing (DPS-based systems and related dental devices) as the dental segment is a core business.
$23.80M
$0.31
+0.06%
MODD Modular Medical, Inc.
MODD directly manufactures insulin pumps (MODD1 and Pivot), a core medical device product category categorized under Medical Devices & Biometrics.
$21.71M
$0.41
+2.80%
BMGL Basel Medical Group Ltd Ordinary Shares
BMGL provides hospital-style healthcare services, including inpatient/outpatient care via clinics and integrated care delivery.
$21.68M
$1.17
+0.43%
GTHP Guided Therapeutics, Inc.
LuViva is a point-of-care diagnostic device used for cervical cancer screening, which aligns with Diagnostic Equipment.
$20.90M
$0.25
BEAT HeartBeam, Inc.
Direct diagnostic equipment derived from HeartBeam's synthesized 12-lead ECG device.
$20.71M
$0.60
+3.62%
KPEA Kun Peng International Ltd.
The business includes health care equipment-based services and devices, aligning with medical devices & equipment.
$20.00M
$0.05
NSYS Nortech Systems Incorporated
Medical Device Components manufacturing and assembly for regulated markets.
$18.97M
$7.14
+2.73%
NXL Nexalin Technology, Inc.
Core product is non-invasive neuromodulation devices for brain stimulation (Gen-2 SYNC, Gen-3 HALO).
$18.81M
$1.09
+3.30%
ALLR Allarity Therapeutics, Inc.
Allarity provides laboratory services linked to its DRP companion diagnostics; falls under laboratory testing/advisory services.
$18.27M
$1.26
+7.20%
COCH Envoy Medical, Inc.
Envoy Medical designs and manufactures implantable medical devices with biometric sensing capabilities (Acclaim CI and Esteem FI-AMEI).
$17.19M
$0.80
-0.05%
TOMZ TOMI Environmental Solutions, Inc.
Product category aligns with healthcare-themed medical devices and equipment, including disinfection hardware (SteraMist SIS/CES).
$16.66M
$0.85
+4.81%
← Previous
1 ... 7 8 9 10 11 ... 12
Next →
Showing page 9 of 12 (1105 total stocks)

Loading company comparison...

Loading research report...

BEAT HeartBeam, Inc.

HeartBeam Receives FDA NSE Decision on 12‑Lead ECG Software, Pursues Appeal and Parallel Resubmission

Nov 27, 2025
TOMZ TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions Adds $3 Million Custom Integration Pipeline with Life‑Sciences Partners

Nov 27, 2025
VNRX VolitionRx Limited

VolitionRx Secures First Human Oncology Sale of Nu.Q® Cancer Assays to France’s Hospices Civils de Lyon

Nov 25, 2025
ICCM IceCure Medical Ltd

IceCure Reports Nine‑Month Financial Results for 2025, Highlights Regulatory Wins and Ongoing Losses

Nov 19, 2025
NXL Nexalin Technology, Inc.

Nexalin Announces Positive Case Study Showing 15 mA Device Achieves Abstinence in Gambling‑Alcohol Co‑Diagnosis

Nov 19, 2025
ICCM IceCure Medical Ltd

IceCure Secures Swiss Regulatory Approval for ProSense Cryoablation System, Expanding European Footprint

Nov 18, 2025
MODD Modular Medical, Inc.

Modular Medical Secures IRB Approval to Advance Pivot Patch Pump Human Study

Nov 18, 2025
TOMZ TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions Secures $20 Million Equity Line of Credit and Files $50 Million Shelf Registration

Nov 17, 2025
ICCM IceCure Medical Ltd

IceCure Medical Faces Nasdaq Bid‑Price Deficiency, Faces 180‑Day Compliance Window

Nov 15, 2025
RVP Retractable Technologies, Inc.

Retractable Technologies Reports Q3 2025 Results: Revenue Slightly Down, Operating Loss Narrowed

Nov 15, 2025
TOMZ TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions Reports Q3 2025 Earnings: Revenue Misses Estimates, EPS Meets Forecast

Nov 15, 2025
BEAT HeartBeam, Inc.

HeartBeam Reports Q3 2025 Results, Misses EPS Estimates Amid Tight Liquidity

Nov 14, 2025
MLSS Milestone Scientific Inc.

Milestone Scientific Reports Q3 2025 Earnings: Revenue Slightly Down, Cost Cuts, and Growing Medical Segment

Nov 14, 2025
MODD Modular Medical, Inc.

Modular Medical Files 510(k) for Pivot Tubeless Patch Pump, Targeting $3 B Almost‑Pumper Market

Nov 14, 2025
TELA TELA Bio, Inc.

TELA Bio Reports Q3 2025 Results: Revenue Misses Estimates, Net Loss Beats Forecast, Announces $13 Million Equity Offering

Nov 14, 2025
NXL Nexalin Technology, Inc.

Nexalin Secures Exclusive Israeli Distributor for Gen‑2 SYNC Device Following Ministry Approval

Nov 13, 2025
RMTI Rockwell Medical, Inc.

Rockwell Medical Reports Q3 2025 Earnings: Revenue Falls 44%, Adjusted EBITDA Turns Positive

Nov 12, 2025
COCH Envoy Medical, Inc.

Envoy Medical Reports Q3 2025 Results, Extinguishes $32 Million Debt, Raises $16 Million, and Advances Acclaim Cochlear Trial

Nov 10, 2025
ELUT Elutia Inc.

Elutia Inc. Reports Q3 2025 Earnings: Revenue Misses Estimates, EPS Below Forecast, Gross Margins Expand

Nov 07, 2025
NXL Nexalin Technology, Inc.

Nexalin Secures FDA Acceptance of Gen‑2 SYNC Q‑Submission, Advancing Alzheimer’s Device to U.S. Trials

Nov 05, 2025
COCH Envoy Medical, Inc.

Envoy Medical Enrolls First Three Patients in Final Stage of Acclaim Cochlear Implant Trial

Nov 04, 2025
BDMD Baird Medical Investment Holdings Limited

Baird Medical Completes First Bone Tumor Ablation in Egypt, Expanding MWA Presence in MENA Region

Nov 03, 2025
FEMY Femasys Inc.

Femasys Secures FDA IDE Approval for FemBloc Trial and Raises $12 Million in Convertible Notes

Nov 03, 2025
MODD Modular Medical, Inc.

Modular Medical Validates Pivot Manufacturing Line Ahead of Q1 2026 Launch

Nov 03, 2025
NXL Nexalin Technology, Inc.

Nexalin Receives Israeli Ministry of Health Approval for Gen‑2 SYNC Neurostimulation Device

Oct 30, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Showcased at TME Fall Summit, Highlighting Cryoablation Advances Post-FDA Authorization

Oct 13, 2025
ICCM IceCure Medical Ltd

IceCure Medical to Attend Maxim Growth Summit Following Landmark FDA Authorization

Oct 09, 2025
ICCM IceCure Medical Ltd

IceCure Medical's ProSense® Cryoablation Granted Landmark FDA Marketing Authorization for Low-Risk Breast Cancer in Women Aged 70+

Oct 03, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Showcased at European Society of Breast Imaging Congress 2025, Highlighting De-Escalation of Care

Sep 30, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Featured at CIRSE 2025 Annual Meeting with Positive Clinical Results from Independent Studies

Sep 22, 2025
ICCM IceCure Medical Ltd

IceCure Granted U.S. Patent Allowance for Next-Generation XSense™ Cryoprobes

Sep 18, 2025
ICCM IceCure Medical Ltd

IceCure Receives Israeli Regulatory Approval for Next-Generation XSense™ Cryoablation System

Sep 15, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Cryoablation Achieves Highest Complete Ablation Rate in THERMAC Trial Publications

Sep 08, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Significantly Reduces Abdominal Wall Endometriosis Pain in Independent Study

Sep 04, 2025
ICCM IceCure Medical Ltd

IceCure Reports H1 2025 Financial Results, Highlights Successful $10 Million Rights Offering

Aug 13, 2025
ICCM IceCure Medical Ltd

IceCure's $10 Million Rights Offering Closes Approximately Two Times Over-Subscribed

Jul 29, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Showcases 99% Recurrence-Free Rate in Japanese Breast Cancer Study, Wins Award

Jul 25, 2025
ICCM IceCure Medical Ltd

IceCure Commences Rights Offering to Raise Up to $10 Million

Jul 10, 2025
ICCM IceCure Medical Ltd

IceCure Reports Preliminary Q2 2025 Financial Results with Revenue Impacted by Geopolitical Conflict

Jul 03, 2025
ICCM IceCure Medical Ltd

IceCure Announces Record Date for Rights Offering to Raise Up to $10 Million

Jun 25, 2025
ICCM IceCure Medical Ltd

IceCure Receives U.S. Patent Allowance for Novel Cryogen Flow Control to Optimize Patient Outcomes

Jun 09, 2025
ICCM IceCure Medical Ltd

IceCure Medical Reports Q1 2025 Financial Results, Secures Bridge Loan from Largest Shareholder

May 28, 2025
ICCM IceCure Medical Ltd

IceCure Reports High Interest from Breast Surgeons at ASBrS Annual Meeting Following Positive FDA Development

May 06, 2025
ICCM IceCure Medical Ltd

FDA Outlines Clear Path for IceCure's ProSense® Marketing Authorization in Early-Stage Breast Cancer for Women 70+

Apr 30, 2025
ICCM IceCure Medical Ltd

IceCure Exhibits ProSense® and Sponsors Sold-Out Breast Cryoablation Courses at SBI Symposium

Apr 28, 2025
ICCM IceCure Medical Ltd

IceCure Medical Reports Full Year 2024 Financial Results, 42% North American Sales Growth

Mar 27, 2025
ICCM IceCure Medical Ltd

IceCure's ICESECRET Kidney Cancer Study Interim Results Presented at European Association of Urology Conference

Mar 24, 2025
ICCM IceCure Medical Ltd

FDA Marketing Authorization for IceCure's ProSense® Breast Cancer Indication Delayed Beyond Q1 2025

Mar 20, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Featured in Six Studies at St. Gallen International Breast Cancer Conference

Mar 18, 2025
ICCM IceCure Medical Ltd

IceCure Receives China Patent Allowance for Novel Cryogenic Pump for Next-Generation Cryoablation Technology

Mar 17, 2025

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks